Apyx Medical (APYX) Liabilities from Discontinued Operations (2017)
Apyx Medical's (APYX) quarterly Liabilities from Discontinued Operations came in at 2248000.0 in Q4 2017.
Apyx Medical (APYX) Liabilities from Discontinued Operations (2017) Analysis & Trends
Apyx Medical (APYX) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 2248000.0 in Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2248000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 2248000.0 (changed N/A YoY) and the FY2017 annual result came in at 2248000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was little changed at 2248000.0 in Q4 2017.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 2248000.0 in Q4 2017 to a low of 2248000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Apyx Medical | 136.15 Mn | 108.54 Mn | 8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 2.25 Mn |
| Dec 31, 2017 | 2.25 Mn |